Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy-Reference-Cited by-同舟云学术

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

Published:2000-01-04 Issue:1 Volume:97 Page:315-319
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Kunisada K.,Negoro S.,Tone E.,Funamoto M.,Osugi T.,Yamada S.,Okabe M.,Kishimoto T.,Yamauchi-Takihara K.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference35 articles.

1. Cytokine signal transduction

2. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway

3. Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver.

4. STAT3 complements defects in an interferon-resistant cell line: Evidence for an essential role for STAT3 in interferon signaling and biological activities

5. Activation of Acute Phase Response Factor (APRF)/Stat3 Transcription Factor by Growth Hormone

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the mechanism of curcumin in the treatment of doxorubicin-induced cardiotoxicity based on network pharmacology and molecular docking technology;Medicine;2024-02-16

2. Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of Leptin;International Journal of Molecular Sciences;2024-01-17

3. CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway;iScience;2023-11

4. Leucine zipper protein 1 attenuates pressure overload-induced cardiac hypertrophy through inhibiting Stat3 signaling;Journal of Advanced Research;2023-10

5. Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy;American Journal of Cardiovascular Drugs;2023-09-05